-
About Risen-Sun
About Ruishun
Take innovation as the driving forceand quality as the lifeline -
Market And Products
Market And Products
Take innovation as the driving forceand quality as the lifeline -
Lean Manufacturing
Lean Manufacturing
Take innovation as the driving forceand quality as the lifeline -
Join Us
Take innovation as the driving forceand quality as the lifeline
Take innovation as the driving force and quality as the lifeline
Shandong Risen-Sun Pharmaceutical Co. LTD. will become a respected pharmaceutical enterprise with professional competitive advantage and international competitiveness.
了解更多 +Jingwei Pharmaceutical's product Baishike was selected into the 2023 "Made in Shandong·Qilu Boutique"
Recently, the Shandong Provincial Department of Industry and Information Technology announced the 2023 "Made in Shandong Qilu Premium" list. A total of 123 companies in the province have been selected. Only 6 products from Tai'an City were selected. Baishike® Essence Oxalate produced by Jingwei Pharmaceutical Citalopram tablets were shortlisted due to their strong innovation, excellent quality, outstanding brand, and significant economic and social benefits.
The 2023 "Made in Shandong·Qilu Boutique" selection work was organized by the Provincial Department of Industry and Information Technology, Shandong Radio and Television Station, and the Provincial Quality Management Association in accordance with the relevant requirements of the ""Made in Shandong" Brand Promotion Action Plan", aiming to help "hospitality" Build the "Shandong Good Products Shandong" brand, strengthen the "Made in Shandong" advantageous brand, do a good job in connecting production and sales and market development, promote the effective connection between supply and demand of industrial products, accelerate the improvement of the "Made in Shandong" brand influence and high-end, and enhance the core competitiveness of the brand and sustainable development capabilities.
Baishike® Escitalopram Oxalate Tablets is an antidepressant drug launched by Jingwei Pharmaceutical as the first generic drug in China in 2008. It was included in the second batch of technological innovation projects in Shandong Province in 2016; it was the first to pass the generic drug quality inspection in 2018. and efficacy consistency evaluation, becoming the second over-evaluated drug in Shandong Province to be approved by the State Food and Drug Administration; in 2019, the product was granted the invention patent authorization for the "Related Substance Detection Method"; in 2021, it was awarded the "Excellent Quality Shandong Drug" Construction in Shandong Province Product title, in the same year it was awarded the single champion product in Shandong Province's manufacturing industry; in 2022, its domestic market share surpassed that of the original drug and ranked first in the sales rankings.
In June 2023, the company's new products, Bianxi® Quetiapine Fumarate Tablets and Bibco® Amisulpride Tablets, were approved for marketing one after another. Biosco, BioBio, Biosac... Jingwei Pharmaceutical has accumulated rich experience in R&D and innovation, and its family of drugs in the psychiatric and neurological fields continues to grow.
Obtaining the honor will greatly boost the confidence of the enterprise in development, promote the upgrading of the enterprise's quality management system, accelerate the construction of the comprehensive quality management system, implement the main responsibility of the enterprise's quality, and implement quality integrity into the entire production and operation process. "Pharmaceutical craftsmanship, striving for excellence" is our unchanging commitment, "pursuing high quality and striving for perfection" is our unremitting pursuit. Jingwei's products must be high-quality products.
Contact Phone
Company Address
No. 668 Hengxin street, economic development zone, Ningyang county, Taian city
©2024 Shandong Risen-Sun Pharmaceutical Co. LTD
Powered by www.300.cn | IPV6 access supported SEO